3 unknown, 2 completed. .
Follow Ligands: new trials by email Literature Review of Ligands trials Research Report on Ligands
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments MAbs - Migraine Disorders, Chronic Migraine | Unknown | IRCCS National Neurological Institute "C. Mondino" Foundation | 100 | 2023-05-10 | 2024-08-20 | |
| Biochemical Profiling of Migraine Patients MAbs - Migraine Disorders, Chronic Migraine | Unknown | IRCCS National Neurological Institute "C. Mondino" Foundation | 100 | 2023-05-10 | 2024-09-05 | |
| HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs) - Migraine Disorders, Chronic Migraine | Unknown | IRCCS National Neurological Institute "C. Mondino" Foundation | 60 | 2020-01-14 | 2024-01-16 | |
| Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis [18F] GE-180 - Amyotrophic Lateral Sclerosis (ALS) | Completed | Massachusetts General Hospital | 86 | 2015-11-01 | 2020-05-21 | |
| Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand Norepinephrine Transporter (NET) ligand - Hypoglycemia | Completed | Yale University | 9 | 2011-06-01 | 2020-03-06 |
Migraine Disorders (3) · Amyotrophic Lateral Sclerosis (1) · Hypoglycemia (1)
IRCCS National Neurological Institute "C. Mondino" Foundation (3) · Massachusetts General Hospital (1) · Yale University (1)
Italy (3) · United States (2)
Joseph Masdeu, MD, PhD (1) · Renata Belfort De Aguiar, MD (1) · Suma Babu, MD (1)
R01DK020495 (1)